The genetics and epigenetics of Neonatal Abstinence Syndrome.


Journal

Seminars in fetal & neonatal medicine
ISSN: 1878-0946
Titre abrégé: Semin Fetal Neonatal Med
Pays: Netherlands
ID NLM: 101240003

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 3 2 2019
medline: 27 11 2019
entrez: 3 2 2019
Statut: ppublish

Résumé

Neonatal abstinence syndrome (NAS) due to in-utero opioid exposure is a growing epidemic with significant variability in clinical presentation and severity. Currently, NAS severity cannot be predicted based on clinical factors alone. To date, small studies have identified genetic variants in opioid receptor and stress response genes that are associated with differences in NAS pharmacologic treatment rates and length of hospitalization. In addition, epigenetic variation in the mu opioid receptor (OPRM1) gene has been associated with differences in NAS hospitalization outcomes. Examination of maternal genetic and epigenetic profiles may assist in prediction of NAS severity. Large-scale genomic studies are needed to elucidate the genetic architecture of and epigenetic modification related to NAS in order to develop more tailored personalized treatments for NAS.

Identifiants

pubmed: 30709700
pii: S1744-165X(19)30010-1
doi: 10.1016/j.siny.2019.01.002
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Receptors, Opioid, mu 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-110

Informations de copyright

© 2019 Elsevier Ltd. All rights reserved.

Auteurs

Elisha M Wachman (EM)

Department of Pediatrics, Boston Medical Center, Boston, MA, USA; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA. Electronic address: Elisha.Wachman@bmc.org.

Lindsay A Farrer (LA)

Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, MA, USA. Electronic address: farrer@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH